GT Medical Technologies, Inc. completes acquisition of radioactive seed assets from Perspective Therapeutics, Inc.
Acquiring Company
GT Medical Technologies
Acquired Company
Perspective Therapeutics
TempeRichlandBiotechnologyHealth CareMedicalHealthcareDescription
The strategic acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc., solidifies GT MedTech's position as the sole manufacturer of Cesium-131 brachytherapy seeds for cancer treatments. This acquisition marks a significant investment for GT MedTech to vertically integrate the Cesium-131 manufacturing process, enhancing supply chain competencies and capabilities, and reinforcing the company's commitment to expand adoption of GammaTile® in the U.S.
Quick answer
GT Medical Technologies is acquiring Perspective Therapeutics, announced April 15, 2024. GT Medical Technologies is based in Tempe, Arizona, United States.
- How much did GT Medical Technologies pay for Perspective Therapeutics?
- The deal value was not disclosed.
- What does GT Medical Technologies do?
- GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors.
- Where are GT Medical Technologies and Perspective Therapeutics based?
- GT Medical Technologies is based in Tempe, Arizona, United States. Perspective Therapeutics is based in Richland, Washington, United States.
- Who are the decision-makers at GT Medical Technologies?
- Fundz holds 1 contact at GT Medical Technologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- XOMA Corporation successfully acquires Kinnate Biopharma Inc. (April 3, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
Who to call at GT Medical Technologies, and when
When GT Medical Technologies changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day GT Medical Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GT Medical Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GT Medical Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GT Medical Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Perspective Therapeutics?
Perspective Therapeutics was acquired by GT Medical Technologies, based in Tempe. The deal was reported on April 15, 2024. GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT Medical Technologies is privately held and operates in Biotechnology.
When did GT Medical Technologies acquire Perspective Therapeutics?
GT Medical Technologies's acquisition of Perspective Therapeutics was reported on April 15, 2024. The strategic acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc., solidifies GT MedTech's position as the sole manufacturer of Cesium-131 brachytherapy seeds for cancer treatments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Perspective Therapeutics do?
Perspective Therapeutics, Inc. is a biopharmaceutical company focusing on developing targeted alpha radioligand therapies for patients with intractable tumors. It is publicly traded (CATX), operating in Healthcare, and is based in Richland.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.